Allogeneic stem cell transplant in patients with acute myeloid leukemia and karnofsky performance status score less than or equal to 80%: A study from the acute leukemia working party of the European Society for Blood and Marrow Transplantation (EBMT)

Limited data are currently available on the outcome of patients with acute myeloid leukemia (AML) undergoing allogeneic stem cell transplantation (allo‐SCT) with a reduced performance status. We herein present the results of a registry study on 2,936 AML patients undergoing allo‐SCT in first remissi...

Descripción completa

Detalles Bibliográficos
Autores principales: Saraceni, Francesco, Labopin, Myriam, Forcade, Edouard, Kröger, Nicolaus, Socié, Gerard, Niittyvuopio, Riitta, Cornelissen, Jan J., Labussière‐Wallet, Hélène, Blaise, Didier, Choi, Goda, Byrne, Jenny L., Guillerm, Gaelle, Marchand, Tony, Esteve, Jordi, Bazarbachi, Ali, Savani, Bipin, Olivieri, Attilio, Nagler, Arnon, Mohty, Mohamad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826477/
https://www.ncbi.nlm.nih.gov/pubmed/33242374
http://dx.doi.org/10.1002/cam4.3593

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826477/
https://www.ncbi.nlm.nih.gov/pubmed/33242374
http://dx.doi.org/10.1002/cam4.3593

Ejemplares similares